Chimeric Antigen Receptor‐Macrophage Therapy Enters the Clinic: The First‐in‐Human Trial for HER2 <sup>+</sup> Solid Tumors

Authors

Institutions

Publication Details

Journal
MedComm
Published
2025-08-27
DOI
https://doi.org/10.1002/mco2.70374
Citations
5
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
5.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chimeric Antigen Receptor‐Macrophage Therapy Enters the Clinic: The First‐in‐Human Trial for HER2 + Solid Tumors

Wenxue Ma, Catriona H. M. Jamieson
5 citations
MedComm
CAR-T cell therapy research
5.23
article

Chimeric Antigen Receptor‐Macrophage Therapy Enters the Clinic: The First‐in‐Human Trial for HER2 + Solid Tumors

Wenxue Ma, Catriona H. M. Jamieson
article en
5 citations

Abstract

No abstract available for this paper.
MedCommVol. 6(9)
University of California San Diego (US)
National Aeronautics and Space Administration, National Institutes of Health, National Center for Advancing Translational Sciences
Zero hunger
Openalex Percentile: Top 4%
CAR-T cell therapy research
5.23
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Chimeric Antigen Receptor‐Macrophage Therapy Enters the Clinic: The First‐in‐Human Trial for HER2 <sup>+</sup> Solid Tumors — Wenxue Ma, Catriona H. M. Jamieson · MedComm (2025) | TGRS Research Map | TGRS